Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE985
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,581
Award facts
- Contract value 100% obligated
- $10,581.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,581.12 on January 28, 2026, for the supply of Dupixent 300 mg/2 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 29, 2026, to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication used to treat moderate-to-severe eczema, asthma, and other allergic conditions, representing a critical pharmaceutical commodity for military healthcare systems.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military medical facilities and other federal healthcare programs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that has consistently demonstrated the capability to fulfill federal medical supply requirements through competitive procurement processes, supplying a diverse portfolio of brand-name and generic medications, vaccines, and medical devices to support military healthcare worldwide.
Quick answers
Who was awarded contract SPE2DR26FE985?
SPE2DR26FE985 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FE985 worth?
The government has obligated $10,581 on SPE2DR26FE985.
Is contract SPE2DR26FE985 an order under another contract?
Yes. SPE2DR26FE985 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE985 competed?
The extent of competition for SPE2DR26FE985 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award